2006Unpublished venueRequires access

Clinical Study of Shenmai injection treatment for patients with cardio-toxicity caused by anthracycline

Ling Hua-hai

Open publisher page 0 citations

Abstract

Objective:To investigate the therapeutic effect and toxicity of Shenmai injection treatment for patients with cardio-toxicity of anthracycline. Methods: In a radomized tvlal,82 patients with malignamt tumor who received combined chemotherapy were devided into treatment group (Shenmai injection 50ml+chemotherapy,n=35) and control group(only chemotherapy,n=47). Results: The effective rates of two groups showed no marked difference (treatment group 48.6%, control group 42.6%).Cardio-toxicity was more serious in the control group (P0.05). Leucopenia had very significant differences between two groups (P0.01). Conclusion: Shenmai injection can significantly reduce the side effect caused by chemotherapy of anthracycline, ,reduce the incidence of leuc- openia and cardio-toxicity to sustain the treatment.

About this research paper

What this paper is about

Objective:To investigate the therapeutic effect and toxicity of Shenmai injection treatment for patients with cardio-toxicity of anthracycline. Methods: In a radomized tvlal,82 patients with malignamt tumor who received combined chemotherapy were devided into treatment group (Shenmai injection 50ml+chemotherapy,n=35) and control group(only chemotherapy,n=47). Results: The effective rates of two groups showed no marked difference (treatment group 48.6%, control group 42.6%).Cardio-toxicity was more serious in the control group (P0.05). Leucopenia had very significant differences between two groups (P0.01). Conclusion: Shenmai injection can significantly reduce the side effect caused by chemotherapy of anthracycline, ,reduce the incidence of leuc- openia and cardio-toxicity to sustain the treatment.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To investigate the therapeutic effect and toxicity of Shenmai injection treatment for patients with cardio-toxicity of anthracycline. Methods: In a radomized tvlal,82 patients with malignamt tumor who received combined chemotherapy were devided into treatment group (Shenmai injection 50ml+chemotherapy,n=35) and control group(only chemotherapy,n=47). Results: The effective rates of two groups showed no marked difference (treatment group 48.6%, control group 42.6%).Cardio-toxicity was more serious in the control group (P0.05). Leucopenia had very significant differences between two groups (P0.01). Conclusion: Shenmai injection can significantly reduce the side effect caused by chemotherapy of anthracycline, ,reduce the incidence of leuc- openia and cardio-toxicity to sustain the treatment.

Key concepts: Toxicity, Medicine, Anthracycline, Chemotherapy, Incidence (geometry), Cardiac toxicity, Internal medicine, Anesthesia

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical Study of Shenmai injection treatment for patients with cardio-toxicity caused by anthracycline — Research Paper | ScholarLens